Lee Ainslie Teva Pharmaceutical Industries LTD Transaction History

Maverick Capital LTD

$6.78 Billion
Q3 2025

A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Maverick Capital LTD holds 4,300,520 shares of TEVA stock, worth $109 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

4,300,520

Previous 4,377,690 1.76%

Holding current value

$109 Million

Previous $73.4 Million 18.4%

% of portfolio

1.28%

Previous 1.26%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$15.38 - $20.2 $1.19 Million - $1.56 Million	-77,170 Reduced 1.76%	4,300,520 $86.9 Million
Q2 2025 Aug 14, 2025	BUY	$12.82 - $18.15 $55.7 Million - $78.9 Million	4,347,398 Added 14351.64%	4,377,690 $73.4 Million
Q1 2025 May 15, 2025	BUY	$14.67 - $22.01 $236,729 - $355,175	16,137 Added 114.0%	30,292 $465,000
Q4 2024 Feb 14, 2025	SELL	$16.43 - $22.77 $897,472 - $1.24 Million	-54,624 Reduced 79.42%	14,155 $311,000
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $52,109 - $62,492	3,296 Added 5.03%	68,779 $1.24 Million

Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $101,447 - $138,121	7,938 Added 13.79%	65,483 $1.06 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $58,706 - $79,393	-5,502 Reduced 8.73%	57,545 $811,000
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $243,129 - $318,283	29,942 Added 90.45%	63,047 $658,000
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $130,772 - $187,068	-17,483 Reduced 34.56%	33,105 $337,000
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $16,394 - $21,563	-2,277 Reduced 4.31%	50,588 $380,000
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $179,037 - $243,499	21,416 Added 68.1%	52,865 $467,000
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $250,019 - $298,136	31,449 New	31,449 $286,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $376,086 - $456,868	-44,879 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $1.1 Million - $1.28 Million	-110,962 Reduced 71.2%	44,879 $444,000
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $1.15 Million - $1.42 Million	111,167 Added 248.84%	155,841 $1.8 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $693,130 - $888,753	-80,503 Reduced 64.31%	44,674 $431,000
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $1.07 Million - $1.59 Million	125,177 New	125,177 $1.13 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $3.09 Million - $6.21 Million	-461,715 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $1.3 Million - $2.14 Million	-199,500 Reduced 30.17%	461,715 $4.53 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $4.07 Million - $6.35 Million	661,215 New	661,215 $4.55 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $767,583 - $1.49 Million	-94,530 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $2.29 Million - $2.94 Million	-146,690 Reduced 60.81%	94,530 $1.48 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $3.52 Million - $5.75 Million	241,220 New	241,220 $3.72 Million

Others Institutions Holding TEVA

# of Institutions

668

Shares Held

623M

Call Options Held

30.8M

Put Options Held

18.5M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $28.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account